当前位置: X-MOL 学术Antimicrob. Agents Chemother. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Population pharmacokinetics of piperacillin and tazobactam in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study)
Antimicrobial Agents and Chemotherapy ( IF 4.1 ) Pub Date : 2021-08-30 , DOI: 10.1128/aac.01438-21
Vesa Cheng 1, 2 , Mohd H Abdul-Aziz 1 , Fay Burrows 3 , Hergen Buscher 4, 5 , Young-Jae Cho 6 , Amanda Corley 7 , Arne Diehl 8 , Eileen Gilder 9 , Stephan M Jakob 10 , Hyung-Sook Kim 11 , Bianca J Levkovich 12 , Sung Yoon Lim 6 , Shay McGuinness 9 , Rachael Parke 9, 13 , Vincent Pellegrino 8 , Yok-Ai Que 10 , Claire Reynolds 4 , Sam Rudham 4 , Steven C Wallis 1 , Susan A Welch 3 , David Zacharias 10 , John F Fraser 2, 14, 15, 16 , Kiran Shekar 2, 14, 15, 16 , Jason A Roberts 1, 17, 18 ,
Affiliation  

Our study aimed to describe the population pharmacokinetics (PK) of piperacillin and tazobactam in patients on extracorporeal membrane oxygenation (ECMO), with and without renal replacement therapy (RRT). We also aimed to use dosing simulations to ...

中文翻译:

哌拉西林和他唑巴坦在接受体外膜肺氧合的危重患者中的群体药代动力学(ASAP ECMO 研究)

我们的研究旨在描述体外膜肺氧合 (ECMO) 患者中哌拉西林和他唑巴坦的群体药代动力学 (PK),有和没有肾替代疗法 (RRT)。我们还旨在使用剂量模拟来...
更新日期:2021-09-12
down
wechat
bug